Harmony Biosciences Holdings, Inc.
HRMY
$31.43
$0.491.58%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 21.13% | 17.74% | 20.62% | 22.80% | 25.83% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 21.13% | 17.74% | 20.62% | 22.80% | 25.83% |
| Cost of Revenue | 26.55% | 23.88% | 26.09% | 29.35% | 38.67% |
| Gross Profit | 19.66% | 16.15% | 19.19% | 21.08% | 22.74% |
| SG&A Expenses | 10.12% | 13.96% | 14.60% | 14.83% | 20.87% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18.50% | 15.20% | 32.85% | 34.34% | 47.92% |
| Operating Income | 28.72% | 24.58% | -4.22% | -0.63% | -12.11% |
| Income Before Tax | 31.44% | 36.45% | 5.23% | 10.62% | -1.39% |
| Income Tax Expenses | -15.04% | -11.54% | -10.51% | 3.97% | 94.84% |
| Earnings from Continuing Operations | 51.42% | 57.32% | 10.91% | 12.91% | -18.66% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 51.42% | 57.32% | 10.91% | 12.91% | -18.66% |
| EBIT | 28.72% | 24.58% | -4.22% | -0.63% | -12.11% |
| EBITDA | 25.03% | 21.35% | -3.97% | -0.67% | -10.81% |
| EPS Basic | 50.86% | 59.96% | 14.08% | 18.12% | -14.96% |
| Normalized Basic EPS | 30.97% | 31.12% | 2.96% | 9.54% | -2.24% |
| EPS Diluted | 50.85% | 59.14% | 13.50% | 18.49% | -14.34% |
| Normalized Diluted EPS | 30.47% | 30.20% | 2.24% | 9.17% | -1.74% |
| Average Basic Shares Outstanding | 0.29% | -1.30% | -2.92% | -4.35% | -4.30% |
| Average Diluted Shares Outstanding | 0.77% | -0.60% | -2.31% | -4.16% | -4.98% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |